HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
541.80
+8.88 (1.67%)
At close: Mar 3, 2026, 4:00 PM EST
540.35
-1.45 (-0.27%)
Pre-market: Mar 4, 2026, 8:05 AM EST
HCA Healthcare Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 524.26, with a low estimate of 410 and a high estimate of 635. The average target predicts a decrease of -3.24% from the current stock price of 541.80.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock from 21 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 6 | 5 | 5 | 6 | 7 |
| Buy | 6 | 7 | 7 | 7 | 6 | 6 |
| Hold | 9 | 9 | 9 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 22 | 21 | 20 | 20 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $540 → $585 | Buy | Maintains | $540 → $585 | +7.97% | Feb 25, 2026 |
| UBS | UBS | Strong Buy Maintains $598 → $635 | Strong Buy | Maintains | $598 → $635 | +17.20% | Feb 23, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $420 → $535 | Hold | Maintains | $420 → $535 | -1.26% | Feb 20, 2026 |
| Argus Research | Argus Research | Strong Buy Maintains $530 → $560 | Strong Buy | Maintains | $530 → $560 | +3.36% | Feb 6, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $452 → $481 | Hold | Maintains | $452 → $481 | -11.22% | Jan 30, 2026 |
Financial Forecast
Revenue This Year
79.45B
from 75.60B
Increased by 5.10%
Revenue Next Year
83.38B
from 79.45B
Increased by 4.94%
EPS This Year
30.32
from 28.33
Increased by 7.01%
EPS Next Year
33.44
from 30.32
Increased by 10.31%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 84.4B | 89.3B | |||
| Avg | 79.5B | 83.4B | |||
| Low | 75.5B | 79.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.7% | 12.4% | |||
| Avg | 5.1% | 4.9% | |||
| Low | -0.2% | -0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 32.95 | 36.26 | |||
| Avg | 30.32 | 33.44 | |||
| Low | 26.71 | 29.89 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 16.3% | 19.6% | |||
| Avg | 7.0% | 10.3% | |||
| Low | -5.7% | -1.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.